April2016mclAcadCV

1
Curriculum Vitae
M. Chris Langub Jr.
Health Scientist/Scientific Review Official
January 2016
CONTACT INFORMATION
3182 Wicks Lake Drive Marietta, GA 30062
Office: (404) 488-3585 Mobile: (770)-337-6863 Email: mlangub@cdc.gov
EDUCATION
Postdoctoral Fellowship: University of Kentucky College of Medicine 1996 Neuroscience
Doctoral Degree: University of Kentucky Graduate School 1993 Anatomy
Bachelor’s Degree: University of Louisville 1984 Biology
SKILL SET
Contracts, Cooperative Agreements and Grants for Federal Personnel
Grants Solution System for the CDC
NIH and CDC IMPAC II Data Base Modules (CMT, IAR, QVR, REV)
Program Evaluation
Project and Team Management
Consensus Building, Persuasive and Impactful Public Speaking
PROFESSIONAL EXPERIENCE
2015 – Present: Scientific Review Official (SRO) - National Center for Injury Prevention and Control (NCIPC)
 Senior Advisor: Advises the of Extramural Research Program Office (ERPO) Director regarding Peer
Review related issues including professional and scientific work in the fields of public health,
epidemiology, behavioral science and social science to support and advance the organization's
mission. Top accomplishment: the structuring of Youth Violence Prevention Center for Excellence
(YVPCC) peer review process for FY2015.
 Leadership and Policy: Provided scientific leadership and policy expertise in the development and
execution of the review of research projects, ensuring scientific soundness and technical feasibility
for NCIPC, NCEH and ATSDR Funding Opportunity Announcements (FOA)s.
 Administrative: Composed, analyzed and assessed final reports from Peer Review meetings.
Officially cleared documents and other materials for public dissemination or publication in scientific
and other peer reviewed publications, according to the procedures set forth by the organization.
 Management and Training: Served as acting-ERPO Director when requested, provided management
and oversight ERPO SPOs, SROs, Public Health Analysts (PHAs), grants technical assistants (GTAs) and
contractors in conducting NCIPC/OADS/ERPO business. Trained and mentored three GTA and PHA on
NCIPC and National Center for Environmental Health (NCEH) and Agency for Toxic Substance and
Disease Registry (ATSDR) Peer Review process, conduct and reporting. Managed and trained over 50
science and public health experts on current CDC and Department of Health and Human Services
(DHHS) policies and procedures relevant for peer review.
 Networking and Collaboration: Worked with leaders in other CDC Centers and National Institutes of
Health (NIH) to coordinate and facilitate strategies, programs and procedures to ensure integration
of peer review with broader CDC scientific enterprise. Standing member in NIH/CDC Review Users
Group (RUG) since 2005 and currently part of the NIH Multi-component Application Workgroup.
 Communication and Project Management: Effectively communicated with persons in the public
domain to ensure proper communication of programmatic interests, and CDC/HHS policies and
procedures. Successfully planned and conducted peer review meetings in accordance with Federal

Moises Chris Langub Jr., Ph.D.
2
laws and regulations as implemented via CDC policies and procedures. Worked with Contract Officer
Representative (COR) on the FY15-16 Peer Review Support contract for FY2015-2016.
2011-2015: SRO - National Center for Disease Prevention and Health Promotion (NCCDPHP)
 Senior Advisor and Policy: Advised the ERPO Director on Peer Review related issues including
professional and scientific work in the fields of public health, epidemiology, laboratory science,
health economics, behavioral science and social science to support and advance the organization's
mission. Provided expert policy advice to Director and over 200 science and public health experts on
current CDC and DHHS policies and procedures relevant for NCCDPHP and NCBDDD peer review.
 Leadership: Provided scientific leadership and expertise in the development and execution of the
review of research projects, ensuring scientific soundness and technical feasibility for NCCDPHP and
NCBDDD Funding Opportunity Announcements (FOA)s.
 Administrative: Composed, analyzed and assessed results in Peer Review decisions and relationships
with other U.S. governmental agencies—Federal, state and local organizations. Top accomplishment:
successful review and funding of the NCCDPHP Prevention Research Centers (PRC) which required
over 75 public health and scientific experts. Reviewed and officially cleared documents and other
materials for public dissemination or publication in scientific and other peer reviewed publications,
according to the procedures set forth by the organization.
and oversight to ERPOS SPOs, SROs, PHA and contractors in conducting NCCDPHP/OADS/ERPOS
business. Trained and mentored GTAs and PHAs regarding NCCDPHP and National Center for Birth
Defects and Developmental Disabilities (NCBDDD) Peer Review process, conduct and reporting.
Managed and trained over 200 science and public health experts on current CDC and DHHS policies
and procedures relevant for peer review.
 Networking and Collaboration: Worked with leaders in other organizations (CDC and NIH) to
coordinate and facilitate strategies, programs and procedures to ensure integration of peer review
with broader CDC scientific enterprise. Standing member of the NIH Review Users Group (RUG) and
primary contact with Procurement and Grants Office (PGO). Effectively communicated with persons
in the public domain to ensure proper communication of programmatic interests, and CDC/DHHS
policies and procedures.
 Project Management: Planned and Conducted peer review meetings in accordance with Federal
laws and regulations as implemented via CDC policies and procedures for NCCDPHP and NCBDDD co-
operative agreements and research FOAs. Worked with Contract Officer Representative (COR) on
Peer Review Support Contracts for FY2012-2014.
2006-2011: SRO - National Institute for Occupational Safety and Health (NIOSH)
 Senior Advisor and Management: Advised the Office of Extramural Research (OER) Director
regarding NIOSH Peer Review of extramural grants and co-operative agreements. Technical Monitor
(TM) and manager of the NIOSH National Workforce Assessment. Advised and performed
professional and scientific work to support and advance the organization's mission. Managed site
visit teams for the Education and Research Center (ERC), Construction Research Center (CRC) and
Agriculture Research Center across the country. Top accomplishments: The NIOSH National
Workforce Assessment in which key government, private and public stakeholders produced results
that would drive research and training for occupational safety professionals. Addition of the 17th
and
new ERC in Denver, Colorado.
 Leadership and Policy: Provided scientific leadership and expertise in the development and
for NIOSH Funding Opportunity Announcements (FOA)s. Top accomplishment: Represented NIOSH
in the first World Conference on Research Integrity FY2007 Lisbon, Portugal. Contributing member of
white paper on International Protection of Human Subjects. Provided expert policy advice to NIOSH
Director, Management and Analysis Support Office (MASO) and Procurement and Grants Office
(PGO) leaders as well as science and public health experts on current CDC and DHHS policies and

3
procedures relevant for peer review. Top accomplishments: successful site visit evaluations of ERCs,
CRCs and Agriculture Research Centers across the country.
 Administrative: Composed, analyzed and assessed results in NIOSH Peer Review decisions and
relationships with other U.S. governmental agencies—Federal, state and local organizations. Top
accomplishment: the NIOSH peer review of the World Trade Center (WTC) First Responders' Health
Care co-operative agreement grants for the 9/11 responders and their families. Reviewed and
officially cleared documents and other materials for public dissemination or publication in scientific
and other peer reviewed publications, according to the procedures set forth by the organization.
Point of contact for the NIH/Center for Scientific Review Receipt and Referral Division.
and oversight to ERPO FTEs and contractors in conducting NCIPC/OADS/ERPO business. Also served
as acting Chief of Review when requested and provided managed NIOSH FTEs and contractors in
conducting peer review related business. Trained and mentored GTAs, Scientific Review Officers
(SRO) s regarding NIOSH Peer Review process, conduct and reporting.
 Networking and Collaboration: Worked with leaders in other organizations (CDC and NIH) to
with broader CDC scientific enterprise including the National Workforce Assessment for
Occupational Health and Safety professionals across the country. Standing member of the NIH
Review Users Group (RUG) since 2005.
domain to ensure proper communication of programmatic interests, and CDC/DHHS policies and
procedures. Planned and conducted peer review meetings in accordance with Federal laws and
regulations as implemented via CDC policies and procedures for co-operative agreements, research
and training FOAs. Contract Officer Representative (COR), Technical Monitor and Manager of the
NIOSH Occupational Safety and Health Professionals National Assessment FY2010-11.
2005-2006: SRO - Office of Public Health Research (OPHR)
 Senior Advisor, Policy and Leadership: Advised the Director; regarding Peer Review to support and
advance the CDC mission. Top accomplishments: review services for many of CDC Centers as they
started up their ERPOs. Co-authored the CDC Peer Review Policy Handbook. Provided expert policy
advice on current CDC and DHHS policies and procedures relevant for peer review. Top
accomplishment: successful collaborations among CDC Centers to smooth transition of CDC external
peer review processes. Provided scientific leadership and expertise in the development and
for CDC Funding Opportunity Announcements (FOA). CDC point of contact NIH Center for Scientific
Review (CSR) Receipt and Referral Division and member of the NIH Review Users Group (RUG). Top
accomplishment: worked with CDC Center leadership to move forward CDC Peer Review processes.
 Administrative: Composed, analyzed and assessed results in Peer Review decisions and relationships
with other U.S. governmental agencies—Federal, state and local organizations. Top accomplishment:
crafting of the memorandum of understanding (MOU) with NIH Peer Review Information Technology
(IT) Support FY 2005. Reviewed and officially cleared documents and other materials for public
dissemination or publication in scientific and other peer reviewed publications, according to the
procedures set forth by the organization.
and oversight ERPO SPOs, SROs, PHAs, GPAs GTAs and contractors in conducting OPHR business.
Designated Team Lead for the Peer Review Team - trained and mentored CDC Peer Review
personnel (SRO, GTA and PHA) on process, conduct and reporting of peer review meetings.
 Networking and Collaboration: Collaborated with leaders in other organizations (CDC and NIH) to
with broader CDC scientific enterprise. Top accomplishment: worked with NIH/CSR to establish CDC
Extramural Peer Review policy and process.

4
domain to ensure proper communication of programmatic interests, and CDC/HHS policies and
procedures. Planned and Conducted peer review meetings in accordance with Federal laws and
regulations as implemented via CDC policies and procedures.
2004-2005: Scientific Review Official NIH Center for Scientific Review (CSR)
 Senior Advisor: Advised the Chief of Review Group: Identified, mediated and resolved NIH Peer
Review related issues in the Urogenital, Kidney, and Genitourinary tract Diseases (UKGD) standing
study section and Small Business Innovative Research (SBIR) reviews including fields of science and
social science to support and advance the organization's mission. Top accomplishments: crafting,
management and installation of NIH Director’s appointment memo for the UKGD permanent
members to a standing study section.
 Leadership and Policy: Provided scientific leadership and expertise in the development and
for NIH Funding Opportunity Announcements (FOA). Top accomplishment: elected to the NIH Center
for Scientific Review council FY2005. Provided expert policy advice on current NIH and DHHS policies
and procedures relevant for peer review to over 200 nationally known scientific and public health
experts.
 Administrative: Composed, analyzed and assessed reports from Peer Review meetings. Reviewed
and officially cleared documents and other materials for public dissemination or publication in
scientific and other peer reviewed publications, according to the procedures set forth by the
organization.
 Networking and Collaboration: Worked with leaders in other NIH Centers and Institutes to
with broader NIH scientific enterprise. Worked with CDC to establish CDC Peer Review process
FY2005. Effectively communicated with persons in the public domain to ensure proper
communication of programmatic interests, and NIH/HHS policies and procedures. Planned and
Conducted professional review meetings in accordance with Federal laws and regulations as
implemented via NIH policies and procedures.
1998-2004: Assistant Professor University of Kentucky Medical Center (UKMC)
 Co-Director, Nephrology and Bone Mineral Metabolism Research Laboratory Operations
 Co-Director of Nephrology and Bone Mineral Metabolism Seminar Series
 Director of UKMC General Clinical Research Center (GCRC) Core Laboratory
 Member - Board of Directors National Association of GCRC Core Laboratories
1996-1998: Assistant Research Professor Internal Medicine/Nephrology, Bone Metabolism
PROFESSIONAL ACTIVITY, DEVELOPMENT, AND PUBLIC SERVICE
Scientific Review Special Emphasis Panels Convened:
FY2015 - National Center for Injury Prevention and Control (NCIPC) and National Center for Environmental
Health (NCEH)
ZCE1 EEO 01 R, CE15-001 (R01) Grants to Prevent Violence and Violence-Related Injury ($23,544,109)
ZCE1 EEO 02 1 CE15-002 (U-01) Cooperative agreements for the CDC National Centers for Excellence in
Youth Violence Prevention: Building the Evidence for Community-and Policy-level Intervention
($46,414,622)
ZEH1 EEO 01 1 EH15-001-(R01) Grants for the Environmental Health Specialists Network (EHS-Net) -
Practice Based Research to Improve Food Safety ($5,854,292)

5
FY2015 - National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) and National Center
for Birth Defects and Developmental Disabilities (NCBDDD)
ZDP1 EEO 12 R, Panel 12 DP15-001 (U-01) Cooperative agreements for Natural Experiments of the Impact
of Population-targeted Health Policies to Prevent Diabetes and its Complications ($32,446,860)
ZDP1 EEO 01 R, Panel 1 DP15-004 (U-01) Cooperative agreements to Establish a Vision and Eye Health
Surveillance System for the Nation ($15,900,619)
ZDP1 EEO 02 R, Panel 2 DP15-003 (U-01) Cooperative agreements for Comparison and Validation of
Screening Tools for Substance Use Among Pregnant Women ($4,504,987)
ZDD1 EEO 03 R, Panel 3 DD15-001 (U-01) Cooperative agreements for Public Health Research on
Modifiable Risk Factors for Spina Bifida ($2,722,373)
ZDP1 EEO 04 R, Panel 4 DP15-006 (U-01) Cooperative agreements for Investigating New Approaches for
Tobacco Surveillance Systems ($13,984,792)
ZDP1 EEO 05 R, Panel 5 DP15-010 (U-01) Cooperative agreements for Interstitial Cystitis Epidemiologic
Study, Translation, and Education ($2,999,999)
ZDP1 EEO 06 R, Panel 6 DP15-009 (U-01) Cooperative agreements for Improving Surveillance and
Prevention of Epilepsy Burden in US Communities ($5,099,055)
ZDP1 EEO 07 R, Panel 7 DP15-005 (U-01) Cooperative agreements for Evaluation of a Stepped Care
Approach for Perinatal Depression Treatment in Obstetrics and Gynecology Clinics ($14,766,235)
ZDP1 EEO 08 R, Panel 8 DP15-007 (U-01) Cooperative agreements for Effectiveness of Teen Pregnancy
Prevention Programs Designed Specifically for Young Males ($59,277,200)
ZDD1 EEO 09 R, Panel 9 DD15-003 (U-01) Cooperative agreements for Using longitudinal Data to
Characterize the Natural History of Fragile X Syndrome to Improve Services and Outcomes ($5,240,260)
ZDD1 EEO 01 R, DD14-003 (U01) Cooperative agreements for Pilot Interventions to Promote the Health of
People with Blood Disorders ($3,274,039)
ZDD1 EEO 02 R, DD14-002 (U01) Cooperative agreements for Research Approaches to Improve the Care
and Outcomes of People Living with Spina Bifida ($12,235,565)
ZDD1 EEO 03 R, DD14-001 (U01) Cooperative agreements for Surveillance and Research of Muscular
Dystrophies and Neuromuscular Disorders ($30,872,650)
ZDP1 EEO 01 R, DP14-002 (U01) Cooperative agreements for Improving Access to Eye Care Among Persons
at High Risk of Glaucoma ($25,133,047)
ZDP1 EEO 01 R, DP14-004 (U01) Cooperative agreements for Longitudinal Study of a Population-based
Cohort of People with Lupus ($14,932,873)
ZDP1 EEO R, DP14-001 and 002 (U01) Cooperative agreements for Healthy Brain Initiative Networks (HBIN)
($4,378,662)
ZDP1 EEO R, DP14-011, SIPS 015, 017 and 018 (U01) Cooperative agreements for Skin Cancer (Self-
Management, Registry and Communications) ($14,684,134)
ZDP1 EEO R, DP14-011, SIPs 006, 007 and 008 (U01) Cooperative agreements for Epilepsy (Self-
Management and Communication) ($10, 734,656)
ZDP1 EEO R, DP14-011, SIPs 033 and 034 (U01) Cooperative agreements for Infection Prevention Strategies
(STD) ($1,659,545)

6
ZDP1, EEO R, DP14-011, SIP 023 (U01) Cooperative agreements for Progestin Contraception and HIV Risk
($5,987,362)
ZDP1 EEO R, DP14-011, SIPs 016 and 019 (U01) Cooperative agreements for Breast and Colorectal Cancer
(Communications, Registry and Strategies) ($1,223,147)
ZDP1 EEO E1 R, DP14-001 SIP 020 (U01) Cooperative agreements for State-driven Falls Prevention
Dissemination ($1,799,947)
ZDP1 EEO R, DP14-011 SIPs 003, 004 and 005 (U01) Cooperative agreements for Cognitive Health and
Impairment Awareness (Alzheimer’s Disease and Dementia) ($2,183,826)
ZDP1 EEO R, DP14-011 SIPs 030, 031 and 032 (U01) Cooperative agreements for Chronic Disease Self-
management and Workplace Health ($16,199,629)
ZDP1 EEO R, DP14-011 SIPs 024 and 025 (U01) Cooperative agreements for Physical Activity Policy Network
(Sedentary Lifestyles) ($25,140,598)
ZDP1 EEO R, DP14-011 SIP 009 (U01) Cooperative agreements for Surveillance (Youth Alcohol Marketing)
($1,845,990)
ZDP1 EEO R, DP14-011 SIPs 021 and 022 (U01) Cooperative agreements for Global Health Strategies
($4,959,115)
ZDP1 EEO R, DP14-011 SIPs 028 and 029 (U01) Cooperative agreements for Tobacco Cessation (Strategies
and Tools) ($1,283,194)
ZDP1 EEO R, DP14-011 SIPs 012, 013 and 014 (U01) Cooperative agreements for Cancer-Colorectal and
Prostate (Screening and Improvements on Barriers and Communications) ($18,277,054)
ZDP1 EEO R, DP14-011 SIPs 026 and 027 (U01) Cooperative agreements for Nutrition and Obesity Policy
Network (Evidence-based) ($29,572,332)
ZDP1 EEO R, DP14-011 SIPs 010 and 011 (U01) Cooperative agreements for Cancer Care Networks
($21,229,794)
ZDP1 EEO R, DP14-001 (U01) Cooperative agreements for Health Promotion and Disease Prevention
Research Centers (PRC) ($243,227,560)
ZDD1 EEO R, DD13-002 (U01) Cooperative agreements for Evaluation of Treatments and Services Provided
to People with Duchene Muscular Dystrophy (DMD) II ($545,316)
ZDP1 EEO R, DP13-011 SIPs 071 and 072 (U01) Cooperative agreements for Needed Changes or Additions
to Data as Outlined in the National Plan to Address Alzheimer’s Disease and Expansion of the Scientific
Knowledge Regarding Dementia and Co-occurring Chronic Conditions ($399,995)
ZDP1 EEO R, DP13-011 SIP 70 (U01) Identify and Evaluate Evidence and Practiced-based Mall Walking
Program Resource Guide ($374,999)
ZDP1 EEO 7C R, SIP13-068 & SIP13-073 (U01) Cooperative agreements in Tobacco Smoking Cessation-
Physician Informed Decision Making (IDM) Discussions and Use of Participants Registry Quitlines
($2,411,251)
ZDP1 EEO 78 R, DP13-011 SIP 067 & 069 (U01) Cooperative agreements in Colorectal Cancer-Barriers and
Facilitators to Screening and Testing of Tool for Federally Qualified Health Centers to Evaluate Their
Delivery of Preventive Services ($2,174,963)
ZDP1 EEO 7A R, DP13-011 SIP 065 & 066: Special Interest Projects in Cervical, Colorectal, or Breast Cancer
Screening ($1,349,509)

7
ZDP1 EEO 05 R, DP13-001 (U01) Cooperative agreements for Prevalence and Incidence of Inflammatory
Bowel Disease ($4,498,128)
ZDP1 EEO 04 R, DP13-002 (U01) Cooperative agreements for Medicaid Expansion and Reproductive Health
Care for Women ($3,738,908)
ZDD1 EEO 02 R, DD13-002 (U01) Cooperative agreements for Evaluation of Treatments and Services
Provided to People with Duchenne Muscular Dystrophy (DMD) ($550,000)
ZDD1 EEO 01 R, DD13-003 (U01) Cooperative agreements for Birth Defects Study to Evaluate Pregnancy
Exposures (BD-STEPS) ($31,946,372)
ZDP1 EEO 06 R, DP12-001 (U01) Cooperative agreements for DUAL PROTECTION Development and Testing
of a Clinic-Based Intervention to Increase Dual Protection against Unintended Pregnancy and STDs among
High Risk Female Teens ($15,516,854)
ZDP1 EEO 7A R, DP12-011: SIPs 052 (U01) Cooperative agreements for Indoor Tanning, Radiation Exposure
and Innovative Tobacco Cessation ($4,196,214)
ZDP1 EEO 7C R, DP12-011: SIPs 053 (U01) Cooperative agreements for Medical Knowledge and Practice in
Physical Activity, Nutrition and Obesity Counseling for Primary Cancer Prevention ($3,481,541)
ZDP1 EEO 8H R, DP12-011: SIPs 054, 055 & 060 (U01) Cooperative agreements for Nutrition and Obesity
Policy Research Center ($1,259,394)
ZDP1 EEO 7E R, DP12-011 SIPs 056 and 057 (U01) Cooperative agreements for Epilepsy Coordinating and
Collaborating Centers ($1,499,423)
ZDP1 EEO 70 R, DP12-011: SIPs 058 &1 059 (U01) Cooperative agreements for Community-based Fall
Prevention Research and Mobility Assessment in Older Adult Populations ($8,075,256)
ZDP1 EEO 8H R, DP12-011 SIPs 061 and 062 (U01) Cooperative agreements for Nutrition and Obesity Policy
Research: Coordinating and Collaborating Center ($1,259,394)
ZDP1 EEO 8F R, DP12-011 SIP 063 (U01) Cooperative agreements for Evaluation of School Salad Bars as a
Public Health Intervention ($1,399,148)
ZDP1 EEO 8G R, DP12-011 SIP 064 (U01) Cooperative agreements for Pregnancy Prevention Needs of HIV-
Infected Women ($599,880)
ZDD1 EEO 05 R, Research & Training (U01) Cooperative agreements for Research and Training
($55,343,061)
ZDD1 EEO 01 R, DD12-001 (U01) Cooperative agreements for Data Coordinating Center for Autism and
Other Developmental Disabilities Research and Epidemiologic Studies ($6,506,903)
ZDD1 EEO 03 R, DD12-002 (U01) Cooperative agreements for A Pilot Surveillance System for High
Impact/Low Prevalence Congenital and Inherited Conditions ($3,879,042)
ZDD1 EEO 04 R, DD12-003 (U01) Cooperative agreements for Reducing Health Disparities among People
with Intellectual Disabilities ($4,044,928)
ZDD1 EEO 02 R, DD12-005 (U01) Development and Evaluation of a Clinic-based Screening and Brief
Intervention (SBI) for Changing Behaviors Related to Cytomegalovirus Transmission in Pregnant Women
($1,494,694)
FY2011 - National Institute of Occupational Safety and Health (NIOSH)
ZOH1 EEO 51 1, (U50) NIOSH Agriculture Research Center Grants Special Emphasis Panel ($101,643,535)

8
ZOH1 EEO 50 1, NIOSH Education and Research Center (ERC) Special Emphasis Panel ($41,591,519)
ZOH1 EEO 51 1, (T32) NIOSH Training Program Grants (TPG) Special Emphasis Panel ($1,400,000)
ZOH1 EEO 50 1, NIOSH Education and Research Center (ERC) Special Emphasis Panel ($39,702,770)
ZOH l SBO 50 1, (U50) Centers for Agricultural Disease and lnjury Research, Education, and Prevention
($6,265,804)
ZOH1 EEO 52 R, (U50) Centers for Agricultural Disease and lnjury Research, Education, and Prevention
($5,191,220)
ZOH1 BSI 50 1, (T32) NIOSH Training Program Grants (TPG) Special Emphasis Panel ($620,174)
ZOH1 EEO 51 R, NIOSH Education and Research Center (ERC) Special Emphasis Panel ($10,760,132)
FY2007 - National Institute of Occupational Safety and Health (NIOSH) – Archived Records
FY2006 - National Institute of Occupational Safety and Health (NIOSH) - Archived Records
FY2005 - NIH Center for Scientific Review – Standing Study Section Committee UKGD; R01, R21, R03, SBIR R43
and 44 - Archived Records
Leadership and Professional Development Workshops and Seminars:
NIH/Center for Scientific Review committees:
NIH/Review Users Group (RUG) 2005-present
NIH/CSR SRO Handbook Committee 2005-2009
NIH/CSR Desktop Users Group 2004-2005
NIH/CSR SRA Council 2004-2005
1999 Executive Leadership Development for Medical Professionals UK College of Business
and Economics, Lex., KY
1999 Navigating the clinical research process-Investigator Training UK College of Medicine,
Lex., KY
2002 NCRR Bioinformatics Conference- Bioinformatics and MicroArray
Technology
Boston, MA
2004 ASBMR/NIH Conference: Anabolics for Treatment of
Osteoporosis
Bethesda, MD
2004 ACS ProSpective Conference Series: Advanced Microarray
Strategies for Biopharmaceuticals
Boston, MA
2004 6th Annual NIH SBIR-STTR Conference Bethesda, MD
2004 NIH Joint BECON/BISTIC 2004 Symposium Bethesda, MD
2004 NIH Women’s Health Interdisciplinary Research Symposium Bethesda, MD
2007 ESF-ORI World Conference on Research Integrity Lisbon, Portugal
2007 NIH Sex (Gender) Race, & Ethnicity Inclusion in Clinical Research Bethesda, MD

9
2007 NIH Advancing Human Subjects Protection Pittsburgh, PA
2008 Franklin Covey-7 Habits for Managers
Emory University-Essentials in Delegation
Emory University-Executive Presence for Non-Executives
Emory University-Advance Skills for Powerful Presentations
Atlanta, GA
2010 Dale Carnegie Training-Communication with Diplomacy & Tact Atlanta, GA
2011 The Evaluators’ Institute - Outcome and Impact Assessment Atlanta, GA
Scientific Membership Affiliations:
American Society for Nephrology, Endocrine Society, American Society for Bone and Mineral Research
Society, American Association for the Advancement of Science, International Bone and Mineral Society,
International Society of Bone Morphometry, Society for Neuroscience, University of Kentucky Bone
Research Forum
University of Kentucky Medical Center committees:
GCRC Scientific Review Committee (ex officio) 2000-2003
GCRC Advisory Committee (ex officio) 2000-2003
College of Medicine Student Candidate Interviewer 1998-2003
Scientific Service:
Reviewed for the following Scientific Journals: Journal of American Society of Nephrology, Clinical
Nephrology, Journal of Chemical Neuroanatomy, Brain Research
Public Service:
Board of Directors -Central KY Riding for the Handicapped - 2002-2004
Member–Faith Lutheran Church Council Lexington, KY 1998-2000
Assistant Scout Master BSA Troop 97-Lexington, KY 1994-1996
Vice-President-Willow Point Homeowners’ Assoc., Marietta, GA 2007-2009
North Atlanta Soccer Association, Marietta, GA 2007-2008
STUDENT ADVISING ACTIVITIES
Year Advisee Role
1998-2003 Students:
Jacob Yunker,
Kevin Barker
Chad Hatfield
Jay Lakhani
Mark Ball
Preceptor
Professionals:
Stefan Kiessling, MD
Stacey Page, DMD
Charles King, DMD
Li Hao, Ph.D.
Co-Preceptor

10
HONORS AND AWARDS
CDC - On the Spot Awards, 2005-present
CDC - promotion to GS 14/10, 2008
NIH/CSR - promotion to GS 14/6, 2005
International Society of Bone Morphometry, Young Investigator Award, 2000
Advances in Mineral Metabolism, Award, 1999
College of Medicine Research Award, Univ. of Kentucky, 1998
SPEAKING ENGAGEMENTS
SEMINARS
1995 UKMC, Dept. of Internal Medicine: “Distribution of natriuretic peptide mRNAs and the mRNAs
of their respective receptors, the NPR-A and NPR-B in brain”
1995 UKMC, Nephrology, Bone and Mineral Metabolism: “Vitamin D and estrogen receptor mRNA
expression in intestinal and kidney cells”
1996 UKMC, Nephrology, Bone and Mineral Metabolism,“Natriuretic peptide systems and chronic
renal failure”
1996 UKMC, Forum for Reproductive Sciences: "Retinoid X receptors in the hypothalamus"
1998 UKMC, Dept. of Internal Medicine Research Seminar: “Expression of PTH/PTHrP receptor mRNA
parallels bone turnover in dialyzed patients”
1998 UKMC, Nephrology Research Conference: “Finding a model to study PTH/PTHrP receptor
function in chronic renal failure setting”
1999 UKMC, Nephrology Research Conference: “Potential role of OPG and RANKL in renal bone
disease”
1999 UKMC, Forum for Reproductive Sciences: “VDR and RXR expression in aging brain”
2000 UKMC, Bone Research Forum: "Bone turnover regulating factors"
2001 UKMC, Nephrology Research Conference: “In vivo regulation of apoptosis by PTH in metaphyseal
trabecular bone of young rats”
INVITED TALKS
1993 Michigan State University, Dept. of Psychology: "Characterization of estrogen receptor-
containing cells in brain"
1994 Yale University, Dept. of Oby/Gyn: "Synaptic plasticity of estrogen responsive cells in the
anterior preoptic area"
1995 Michigan State University, Dept. of Anatomy: “Neurocircuitry and neurochemistry of estrogen
responsive cells in brain”
1997 UAB 8th
Vascular Biology & Hypertension Research Symposium, ”Natriuretic peptide and
receptor systems in the CNS”
1999 14th
ASBMR/AIMM Conference, "Molecular Bone Morphometry”
2000 33rd
Amer. Soc. of Nephrology, “Increased Osteoprotegerin-Ligand Expression in Bone of
Patients with Renal Osteodystrophy”
2003 NIH/Center for Scientific Review, “A journey from brain to bone”
2008 NIOSH ERC Directors’ Annual Meeting, Chapel Hill NC: “The NIOSH National Workforce
Assessment Project”

11
2008 NIOSH ERC Directors’ Annual Meeting, Salt Lake City, UT: “The NIOSH National Workforce
Assessment Project”
2009 NIOSH ERC Directors’ Annual Meeting, “Update on Workforce Assessment Project”
INTERNATIONAL SEMINARS
1996 Amer. Soc. for Bone and Mineral Research: “Intensity of mRNA expression for IL-6R in
osteoclasts parallels bone resorption in patients with renal osteodystrophy”
1996 Int. Soc. Bone Morphometry (Sardinia, Italy): Molecular mechanisms: “Erosion depth is
paralleled by expression of mRNA for interleukin-6 receptor in osteoclasts”
1998 Amer. Soc. for Bone and Mineral Research: “High serum PTH levels do not downregulate
PTH/PTHrP receptors in osteoblasts of dialyzed patients”
2000 Int. Soc. Bone Morphometry (Scottsdale, AZ): “Relationship of PTH-R expression with
osteoclastic erosion depth in individuals with elevated PTH”
2002 Int. Soc. Bone Morphometry (Edinburgh, Scotland): “Patients with Renal Osteodystrophy Have
Increased RANKL Expression in Bone”
RESEARCH AND/OR CREATIVE PRODUCTIVITY
Publications
Peer Reviewed:
1) LANGUB MC, Maley BE, and Watson RE Jr (1991) Ultrastructural evidence for LHRH neuronal control of
estrogen responsive neurons in the preoptic area. Endocrinology 128: 27-36
2) Watson RE Jr, LANGUB MC, and Landis JW (1992) Further evidence that LHRH neurons are not directly
estrogen-responsive: simultaneous localization of LHRH and estrogen receptor immunoreactivity in the
guinea pig brain. J. Neuroendocrinology 4: 311-317
3) LANGUB MC, Watson RE Jr (1992) Estrogen receptive neurons in the preoptic area of the rat are
postsynaptic targets of a sexually dimorphic enkephalinergic fiber plexus. Brain Research 573: 61-69
4) LANGUB MC, Watson RE Jr (1992) Estrogen receptor-immunoreactive glia, endothelia and ependyma in
guinea pig preoptic area and median eminence: electron microscopy. Endocrinology 130: 364-372
5) Herman James P, LANGUB MC, and Watson RE Jr (1993) Localization of C-type natriuretic peptide mRNA
in rat hypothalamus. Endocrinology 133:1903-1906
6) Watson RE Jr, Hutchinson RK, LANGUB MC, Landis JW, Seksaria S, Rainey DM, and Keil LC (1994)
Colocalization of natriuretic peptide and estrogen receptor immunoreactivities in sexually dimorphic
preoptic nuclei in the female rat. J. Neuroendocrinology 6: 79-87
7) LANGUB MC, Watson RE Jr, and Maley BE (1994) Estrous cycle-associated axosomatic plasticity upon
estrogen receptive neurons in the rat preoptic area. Brain Research 641: 303-310
8) LANGUB MC, Watson RE Jr, and Herman JP (1995) Distribution of natriuretic peptide precursor mRNAs in
the male rat brain. J. Comp. Neurol. 356: 183-199
9) LANGUB MC, CM Dolgas, Watson RE Jr, and JP Herman (1995) Selective expression of B-type natriuretic
peptide receptor mRNA in rat hypothalamus. J. Neuroendocrinology 7: 305-309
10) Watson RE Jr, LANGUB MC, MG Engle, and BE Maley (1995) Suprachiasmatic nucleus efferents synapse
upon estrogen receptor-immunoreactive neurons in the anterior preoptic area of the female rat. Brain
Research 689: 254-264
11) Herman JP, Dolgas CM, Rucker D, and LANGUB MC, (1996) Localization of natriuretic peptide-activated
guanylate cyclase mRNAs in the rat brain. J. Comp. Neurology 369:165-187

12
12) LANGUB MC, Koszewski NJ, Turner HV, MC Monier-Faugere, Z Geng, and HH Malluche, (1996) Bone
resorption and mRNA expression of IL-6 and IL-6 receptor in patients with renal osteodystrophy. Kidney
International 50(2): 515-520
13) Herman JP, Dolgas CM, Marcinek G, and LANGUB MC, (1996) Expression and glucocorticoid regulation of
the natriuretic peptide clearance receptor (NPR-C) mRNA in rat brain and choroid plexus. J. Chemical
Neuroanatomy 11:257-265
14) Sawaya BP, Koszewski NJ, Qi Q, LANGUB MC, Monier-Faugere M-C, Malluche HH, (1997) Secondary
hyperparathyroidism and vitamin D receptor binding to vitamin D response elements in rats with incipient
renal failure. J. Amer. Soc. Nephrology 8(2):271-278
15) HH Malluche, LANGUB MC, MC Monier-Faugere, (1997) Pathogenesis and histology of renal
osteodystrophy. Osteoporosis International 7(20): 7
16) Koszewski NJ, TA Reinhardt, LANGUB MC, HH Malluche HH, RL Horst, (1998) Selectivity of a C-terminal
peptide antibody for different DNA-binding states of the vitamin D receptor. Archives Biochem. Biophysics
349(2): 388-396
17) HH Malluche, LANGUB MC, MC Monier-Faugere, (1999) The role of bone biopsy in clinical practice and
research. Kidney International 56(73): S20-25
18) Zhao G, MC Monier-Faugere, LANGUB MC, Geng Z, Nakayama T, Pike, JW, Chernausek SD, Rosen CJ,
Donahue, L-R, Malluche, HH, Fagin JA, Clemens TL. (2000) Targeted overexpression of insulin-like growth
factor 1 to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast
proliferation. Endocrinology 141 (7):2674-2682
19) LANGUB MC, TA Reinhardt, RL Horst, HH Malluche, NJ Koszewski (2000) Characterization of vitamin D
receptor immunoreactivity in human bone cells. BONE 27(3): 383-387
20) LANGUB MC, MC Monier-Faugere, HH Malluche, (2000) Molecular bone morphometry. J. Pediatric
Nephrology 14:629-635
21) LANGUB MC, MC Monier-Faugere, Koszewski NJ, and HH Malluche (2001) PTH/PTHrP type 1 receptor in
human bone. J. Bone and Mineral Metabolism 16(3); 1-9
22) Brewer LD, Thibault V, Chen K-C, LANGUB MC, Landfield PW, Porter NM (2001) The active metabolite of
vitamin D confers neuroprotection and down-regulates L-type calcium channels in hippocampus neurons.
J. Neuroscience 21(1): 98-108
23) LANGUB MC, JP Herman, HH Malluche, and NJ Koszewski, (2001) Evidence of functional vitamin D
receptors in rat Hippocampus. Neuroscience 104(1): 49-56
24) LANGUB MC, MC Monier-Faugere, G. Wang, JP Williams, NJ Koszewski, and HH Malluche (2003)
Administration of PTH-(7-84) Antagonizes the Effects of PTH-(1-84) on Bone in Rats with Moderate Renal
Failure. Endocrinology 144(4): 1135-1138
25) F-X Yan, LANGUB MC, MA Ihnen, C Hornung, E Juronen, MK Rayens, PJ. Wedlund, and P Fanti (2003)
Expression of phase I and phase II detoxifying enzymes in human parathyroid tissue and impact of their
genetic variation on circulating parathyroid hormone in ESRD patients. Br. J. Clin. Pharmacol 56:68-77
26) AP Alimov, LANGUB MC, HH Malluche, and NJ Koszewski (2003) Sp3/Sp1 in the parathyroid gland:
identification of an Sp-1 DNA element in the PTH promoter. Endocrinology 144 (4): 3138-47
27) AP Alimov, MC LANGUB, HH Malluche, OK Park-Sarge, and NJ Koszewski (2004) Contrasting Mammalian
Parathyroid Hormone (PTH) Promoters: Nuclear Factor-Y Binds to a Deoxyribonucleic Acid Element Unique
to the Human PTH Promoter and Acts as a Transcriptional Enhancer. Endocrinology 145 (6): 2713-20
28) NJ Koszewski, AP Alimov, MC LANGUB, O-K Park-Sarge, HH Malluche (2005) Contrasting Mammalian PTH
Promoters: Identification of Transcription Factors Controlling PTH Gene Expression. Clinical Nephrology 63
(2): 158-162.

13
29) N Christodoulides, S Mohanty, C Miller, MC LANGUB, PN Floriano, P Dharshan, M Ali, E Anslyn, P Fox, and
John T. McDevitt (2005) Application of Electronic Taste Chip System for the Measurement of C-Reactive
Protein in Human Saliva. Lab Chip 5(3) 261-269.
30) Miller, C. S, King, C. P., Jr., LANGUB, MC, Kryscio, R. J., and Thomas, M. V. (2006) Salivary biomarkers of
existing periodontal disease: a cross-sectional study. J Am Dent Assoc 137 (3): 322-329.
31) Christodoulides, N., Floriano, P. N., Miller, C. S., Ebersole, J. L., Mohanty, S., Dharshan, P., Griffin, M.,
Lennart, A., Ballard, K. L., King, C. P., Jr., LANGUB, MC, Kryscio, R. J., Thomas, M. V., and McDevitt, J. T
(2007) Lab-on-a-Chip Methods for Point-of-Care Measurements of Salivary Biomarkers of Periodontitis.
Ann NY Acad Sci 1098: 411-428.
Book Chapters:
1) Malluche HH, LANGUB MC, and Faugere MC, (1997) Bone biopsies: A Modern Approach in Metabolic Bone
Disease edited by Avioli LV and Krane SM, WB Saunders Co., Chapter 8: 237-273
2) Faugere MC, LANGUB MC, and Malluche HH, (1998) Mineralized bone histology in normal and uremic
states in Renal Osteodystrophy edited by Bushinsky DA, Lippincott-Raven, Chapter 3: pp 49-87
3) Jennes L and LANGUB MC (1999) Endocrine targets in the brain in Neuroendocrinology and Physiology in
Medicine edited by Conn M and Freeman M, Humana Press, Chapter 6: pp 95-104
4) Monier-Faugere, MC, LANGUB MC, Malluche, HH (2001): Bone biopsy in patients with renal failure in:
Textbook of Nephrology edited by Massry, SG, Glassock, RJ, Baltimore, Williams and Wilkins, Chapter 98:
pp 1751-1757
5) Monier-Faugere, MC, Sawaya BP, LANGUB MC, and Malluche, HH (2002): Normal Structure and Physiology
in: Calcium in Internal Medicine edited by Morii, H, Nishizawa Y, Massry SG, London, Springer, Chapter 9:
pp 309-322
Letters to the Editor:
LANGUB MC and HH Malluche (2003). Parathyroid Hormone Type 1 Receptor and Human Osteoclasts. J. Bone
and Mineral Metabolism 17(10): p.1916
Grant and Contract Activities:
Role Title Funding agency Project period Project award
PI Regulation of bone
turnover in renal
osteodystrophy
NIH/NIDDK
(KO1DK02830)
12/1/01 –
6/31/04
$243,000
Key Personnel UK- GCRC (Year 18 cont.) NIH/NCRR
(M01RR02602)
Wilson (PI)
6/1/02 – 5/30/07 $11.6 million
Collaborator Saliva analysis with an
array sensor-correlates
with human diseases
NIH/NIDCR
(U01DEI15017)
Anslyn (PI)
9/01/2 - 8/30/06 $5.3 million
Co- PI Renal Osteodystrophy NIH/NIDDK
(RO1DK51530)
Malluche (PI)
7/1/01 to
6/30/05
$ 1.4 million
Co- PI Intermittent Release
Device for Bone
Regeneration
Kentucky Science
& Engineering
Foundation
Puleo (PI)
7/1/03 – 6/31/05 $60,000

14
PI National GCRC Core
Laboratory Web Site
NIH/NCRR
(M01RR02602)
6/1/02 –
5/30/03
$49,000
PI Differential gene expression
after PTH in kidney of rats
with chronic renal failure
Pilot Studies
(MicroArray
Technology) UKRF
4/1/02 –
6/1/02
$5,000
Co-PI Factors other than PTH and
Vit. D in the development
of renal osteodystrophy
Dialysis Clinic Inc.
Malluche (PI)
4/96 to 11/02 $1.2 million
PI VDR/RXR: In Aging NIH/NIA
(RO3 AG14189)
10/1/97 –
4/1/99
$70,182
Co-PI mRNA signals of
parathyroid and calcitriol
receptors
Dialysis Clinic Inc.
Malluche (PI)
4/97 to 11/01 $607,275
PI Cellular effects of anabolic
agents to treat aging bone
Women’s Health
Initiative UKRF
7/1/98 –
7/1/99
$15,000
Other Professional Activities:
1999 – 2003 UKMC Web Page Director for the Division of Nephrology, Bone and Mineral
Metabolism
2001-2003 NIH/NCRR National Core Laboratories Web Development Initiative

April2016mclAcadCV

Recommended

Recommended

More Related Content

What's hot

What's hot (19)

Viewers also liked

Viewers also liked (13)

Similar to April2016mclAcadCV

Similar to April2016mclAcadCV (20)

April2016mclAcadCV